Aldeyra Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% 0.0%
EBIT (mln) -2 -1 -4 -7 -12 -19 -22 -40 -63 -36 -56 -63 -43 -60,117,032
EBIT Δ r/r 0.0% -47.2% 230.0% 97.8% 64.9% 55.9% 20.3% 76.5% 58.9% -42.3% 54.4% 11.5% -31.7% 140479686.0%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 1 2 2 2 2 -1,926,241
EBITDA (mln) -2 -23 -4 -7 -12 -19 -22 -39 -55 -34 -56 -60 -43 -60,117,032
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 0 -21 0 0 -0 0 0 1 -1 -0 1 -1 0 0
Zysk Netto (mln) -2 -23 13 -5 -12 -19 -22 -39 -61 -38 -59 -61 -38 -55,851,444
Zysk netto Δ r/r 0.0% 870.3% -156.6% -139.7% 133.1% 54.7% 19.5% 74.1% 56.4% -38.3% 57.8% 3.6% -38.8% 148768440.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS -7.26 -5.72 3.39 -1.36 -1.4 -1.65 -1.4 -1.79 -2.24 -1.11 -1.1 -1.05 -0.64 -938919.68
EPS (rozwodnione) -0.5 -5.1 -3.14 -1.35 -1.4 -1.65 -1.4 -1.79 -2.24 -1.11 -1.1 -1.05 -0.64 -938919.68
Ilośc akcji (mln) 0 4 0 4 9 11 16 22 27 34 54 58 59 59
Ważona ilośc akcji (mln) 5 5 5 4 9 11 16 22 27 34 54 58 59 59
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD